Retinoids in liver fibrosis and cancer
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Pathobiological functions and metabolism of retinoids (vitamin A and its derivatives) in liver fibrosis and hepatocellular carcinoma (HCC) are discussed in the present review. Retinoic acid (RA, active metabolite) exacerbates liver fibrosis that is not accompanied by hepatic necroinflammation, in which RA acts directly on hepatic stellate cells (HSCs); RA enhances plasminogen activator/plasmin levels and thereby induces proteolytic activation of latent transforming growth factor-β (TGF-β), a strong fibrogenic cytokine, resulting in enhanced collagen production. We have developed a protease inhibitor, camostat mesilate, that suppresses TGF-β activation and thereby inhibits the transformation of HSCs, leading to reduced matrix production by the cells. The compound is effective not only in preventing but also in reducing hepatic fibrosis in rats when administered orally. HCC is refractory to RA due to its local depletion in the tumors and also due to malfunction of its nuclear receptor, retinoid X receptor-α (RXRα) Oral supplementation of a synthetic retinoid named acyclic retinoid led to the disappearance of serum lectin-reactive α-fetoprotein (AFP-L3) and subsequently suppressed posttherapeutic recurrence of HCC in cirrhotic patients. These results suggest eradication of AFP-L3-producing latent malignant clones from the liver by the retinoid. We propose the concept of "clonal deletion" therapy for cancer chemoprevention, a new category of cancer chemotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“in vivo studies suggested that 9-cis retinoic acid exacerbated rat liver fibrosis by inducing the activation of TGF-β1.[174,175]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [175]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rising Incidence of Hepatocellular Carcinoma in the United States
El-Serag, H. B., & Mason, A. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401001 · Cited by 2,853
Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
Huang, M., Ye, Y., Chen, Sr., Chai, Jr., Lu, J., Zhoa, L., Gu, L., & Wang, Z. (1988) · Blood · doi:10.1182/blood.v72.2.567.567 · Cited by 2,445
Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury
Friedman, S. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2247 · Cited by 2,080
Cellular Biology and Biochemistry of the Retinoids
ROBERTS, A. B., & SPORN, M. B. (1984) · The Retinoids · doi:10.1016/b978-0-12-658102-7.50012-9 · Cited by 738
Cytokine therapeutics: lessons from interferonalpha.
Gutterman, J. U. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.4.1198 · Cited by 703
Ikeda, K. (1993) · Hepatology · doi:10.1016/0270-9139(93)90505-h · Cited by 620
Increase in primary liver cancer in the UK, 1979–94
Taylor-Robinson, S. D., Foster, G. R., Arora, S., Hargreaves, S., & Thomas, H. C. (1997) · The Lancet · doi:10.1016/s0140-6736(05)63789-0 · Cited by 506
The retinoids; Biology, chemistry, and medicine
Kaster, P. (1994) · Biochimie · doi:10.1016/0300-9084(94)90131-7 · Cited by 467
(1992) · Springer eBooks · doi:10.1007/978-4-431-68177-9 · Cited by 434
Risk Factors for the Rising Rates of Primary Liver Cancer in the United States
El-Serag, H. B., & Mason, A. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.21.3227 · Cited by 418
Research works printed but not linked: 3
- Sporn M.B., Roberts A.B. & Goodman D.S., Raven Press, New York, 597-630 (1994)
- Flaumenhaft R., S. Kojima, M. Abe & D.B. Rifkin: Activation of latent transforming growth factor β. In: Advances in pharmacology. Vol 24. Eds: August J.T., Anders M.W. & Murad F., Academic Press, San Diego, 51-76 (1993)
- Sporn M.B. & Roberts A.B., Springer-Verlag, Berlin 419- 472 (1990)
Cited by
Nuclear receptors in liver fibrosis
Königshofer, P., Brusilovskaya, K., Petrenko, O., Hofer, B. S., Schwabl, P., Trauner, M., & Reiberger, T. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166235 · Cited by 45
Metadata
- Authors
- Okuno, M.
- Affiliations
- Gifu University (JP)
- Corresponding author
- Okuno, Masataka
- ORCID
- Okuno, Masataka
- Venue
- Frontiers in Bioscience
- Publisher
- IMR Press
- Published
- 2002
- Volume
- 7
- Issue
- 1-3
- Pages
- d204
- ISSN
- 1093-4715 (ISSN-L)
- 1093-9946
- OpenAlex
- W2149637294
- Cited by
- 53
- References
- 48
- Citations by year
- 2024: 1 · 2022: 1 · 2021: 4 · 2020: 3 · 2019: 3 · 2017: 3 · 2016: 3 · 2015: 2 · 2014: 2 · 2013: 1 · 2012: 4
- FWCI
- 1.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Frontiers in bioscience (publishedVersion)
- Frontiers in bioscience (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Ministry of Health, Labour and Welfare
- Ministry of Education, Science and Technology
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Keywords
- retinoids, vitamin A, liver fibrosis, hepatocellular carcinoma, retinoic acid, hepatic stellate cells, TGF-beta activation, plasminogen activator, camostat mesilate, retinoid X receptor alpha, acyclic retinoid, alpha-fetoprotein, chemoprevention, collagen synthesis
- MeSH terms
- Animals, Carcinoma, Hepatocellular, Humans, Liver Cirrhosis, Liver Neoplasms, Retinoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Retinoids in liver fibrosis and cancer. https://app.cochat.ai/papers/10.2741/okuno
- The paper
- Okuno, M. (2002). Retinoids in liver fibrosis and cancer. Frontiers in Bioscience. https://doi.org/10.2741/okuno
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.